Actavis’ Alzheimer’s Drug Approved; Bystolic Gets CRL
Actavis plc ( ACT ) has received mixed news on the regulatory front. While the FDA has issued a complete response letter (CRL) for the company’s hypertension treatment, it has given its approval for the Alzheimer’s drug. […]